 | Special Topic: Microfluidics and Nanofluidics for Immunotherapy
| | | Immunotherapy is an emerging treatment which boosts a person's own immune system to fight diseases such as cancer. There are three different classes of cancer immunotherapy including monoclonal antibodies/checkpoint inhibitors (e.g., anti-PD1), cell-based therapies (e.g., T cells), and cancer vaccines. With advances in biotechnology and better understanding of immuno-oncology, engineered T cells (e.g., CAR T cells) and nanoscale extracellular vesicles (EVs) are often used in cell-based immunotherapies and for personalized medicine. Microfluidics and nanofluidics platforms uniquely offer advantages as novel tools for cell/EV engineering, single cell manipulation and analysis, as well as study of tumor microenvironment. This special issue features articles/reviews on microfluidic-enabled technologies for immunotherapy, immunoengineering, and biomanufacturing of therapeutic cells and EVs. |
Guest Editors: Han Wei Hou, Aram Chung, and Chwee Teck Lim |
| | |
Follow us on social media | | | Copyright © 2025 AIP Publishing. All rights reserved. 1305 Walt Whitman Rd., Melville, NY 11747
You are receiving this email because you have opted-in to receive alerts from us. To guarantee delivery of this email please add alerts@aip-info.org to your address book and safe senders list.
If you no longer wish to receive emails from us then please unsubscribe or amend your settings.
Privacy Policy
| |
|
|
|
| | | |
No comments:
Post a Comment